Injections are frequently administered by occupational health nurses in worksite health promotion programs. The purpose of this study was to examine the effect of varying injection speed on the perception of pain. Fifty workers were given intramuscular (1M) hepatitis B vaccine at injection speeds of 10 and 30 seconds per cubic centimeter (slcc). The perception of pain was measured on a visual analogue scale and reported post-injection at three different time intervals. The results showed that no difference in pain was perceived by participants between the two injection speeds. Results also revealed that women consistently had higher mean pain scores than men and significantly more pain at the 0 hour measurement of the 10 slcc injection. While the results ofthis study 286 indicate no need to administer an 1M injection slower than 10 slcc, occupational health nurses will need to consider gender differences in pain perception when administering injections.
O ccupational health nursing has been called the specialty of prevention. Many worksite health promotion and disease prevention programs involve administering injections. These injections include influenza and hepatitis vaccinations, allergy shots, and tetanusdiptheria boosters. Whatever the purpose, no one is eager to get a "shot." Needles are invasive, they often hurt, and many people are afraid of them. The discomfort during or after an injection may discourage participation in worksite health programs in which participation is optional. Therefore, an occupational health nurse who can administer a relatively painless injection may increase participation in a health promotion program.
The hypodermic needle and syringe were developed in the mid-1800s. These inventions provided a new method of delivering medication and decreased the time required for the drug to take effect. Physicians initially administered injections, giving irritant bismuth or mercury salts in syphilis clinics. Nurses did not begin to administer injections until after penicillin therapy was introduced in 1945, and injections became an increasingly commonplace procedure (Zelman, 1961) . Currently, injections are administered almost exclusively by nurses responsible for administering medications using techniques to relieve or prevent pain from injection (Kruszewski, 1979) .
Injection administration is a basic nursing skill. For this reason, nursing educators invest time in training nurses to administer an injection correctly. Professional journal articles have reinforced the "how to" of appropriate injection techniques for more than 40 years (Campbell, 1995; Dickerson, 1992; Keen, 1986; Kruszewski, 1979; Newton, 1992; Shallowhorn, 1954; Travell, 1955; Zelman, 1961) . One of the basic tenets has always been to inject slowly. Researchers studying injection pain and speed have used rates per cubic centimeter (s/cc) of I second, 5 seconds, 10 seconds, and 30 seconds (Krause, 1997; Scarfone, 1998) . They have found conflicting results. One study suggested no difference between a 1 s/cc injection and a 10 slcc injection (Krause, 1997) . The other study found that a 30 s/cc injection caused significantly less pain than a 5 s/cc injection (Scarfone, 1998) . Other researchers who have studied injection and variables, such as site lesions and positioning, have all referred to the need to inject slowly and used rates of 5 slcc and 10 slcc (Keen, 1986; Kruszewski, 1979; Rettig, 1982) .
In actual clinical practice, nurses can be observed injecting fluid quite rapidly. In an attempt to quantify this observation, administration of approximately 100 vaccinations of varying types was observed. Several nurses in three different clinical settings administered the vaccinations. The clinical settings were two occupational health service s and one community health center. The suggested injection rate of between 5 slcc and 10 slcc was rarely observed, and an injection of 30 slcc was never observed. The slowest injection speed was closer to 4 slcc (Mitchell, 1997) . When one observes this practice or is subjected to it, the following question s arise: Does using a slow rate of injection, as nurses have been taught, decrease the client's perception of pain? Is using a very slow rate even better?
LITERATURE REVIEW
The two types of literature related to injections include: clinical articles in professional journals and data based research articles . The clinical articles can be further divided into those instructing how to administer an injection properly and those discussing the physiologic aspects of injection. Regardless of type, all of these efforts appear to be aimed at the purpose of teaching and under standing properly administered injection techniques causing people the least pain.
Many proposed causes have been identified as affecting intramuscular (1M) injection pain. They include (Campbell, 1995; Keen, 1986; Kruszewski, 1979; Newton, 1992; Shallowhom, 1954; Travell, 1955; Zelman, 1961) The preceding authors encouraged nurses to inject slowly. Some researchers described the rate as constant and gentle (Campbell, 1995) . Others quantified the rate JUNE 2001, VOL. 49. NO.6 
What Does This Mean for Workplace Application?
Occupational health nurses are trained to administer injections slowly. In clinical practice. they may forget this tenet. While a very slow injection of 30 slcc was not shown to be less painful than one administered at 10 s/cc, occupational health nurses should follow current recommendations in the literature and administer injections at a rate of 5 slcc to 10 s/cc. This study revealed that women perceive more pain than men with injections. Occupational health nurses should be aware of potential gender differences in pain perception when administering intramuscular injections.
as 5 slcc, 10 slcc, or 30 slcc when studying injections (Keen, 1986; Krause, 1997; Kruszewski, 1979; Rettig, 1982; Scarfone , 1998) .
Injection pain can result from injury to nerve fibers from mechanical trauma caused by a needle puncture . Pain also can be caused by increased pressure from an accumulation of fluid within the tissues or sudden distention of tissue from rapid introduction of fluid . Pressure is created on nociceptors at the ends of afferent neurons, which respond to chemical , mechanical, or thermal stimuli. The afferent nerves carry signals to the spine and the spinal cord network transmits the signal to the brain (Ludwig-Beymer, 1994; Tortora, 1975) .
As mentioned previously, the incidence of injection pain is dependent to some extent on factors relevant to the particular injectant. Specifically, with hepatitis B vaccine, pain at the site of injection is the most frequently reported side effect, occurring 22% to 75% of the time (Kardi, 1994; Palmovic, 1994; Schiff, 1995) . Local reactions to plasma derived or recombinant hepatitis B vaccine such as soreness, redness , induration, or swelling have been reported as mild and short lived with a duration of 1 to 3 days (Andre, 1987 (Andre, , 1988 Bush, 1991) . Some authors who studied both plasma derived and recombinant hepatitis B vaccine noted that local reaction was not dose related, but that the reactions could have been caused by the aluminum adjuvant in the vaccine or trace impurities (Andre, 1988) . Other authors have noted a dose relation to injection site pain, with a significantly greater number of individuals reporting injection pain when they received the 20 u.g dose of hepatitis B vaccine (Engerix-B®) versus a 10 fLg dose (Schiff, 1995) .
While the supposition that speed of injection affects pain clearly exists, there is a deficit of research on this variable in the literature, particularly in relation to 1M injection. In addition, the results are conflicting. Two studies, which examined injection speed and pain with subdermal or subcutaneous injections, found the
Study Definitions
1. Intramuscular injection is an introduction of fluid into a body muscle by means of a syringe and needle (Kruszewski, 1979) .
2. The deltoid muscle is the muscle mass that inserts on the lower edge of the acromium process. It reaches to the lateral aspect of the arm, in line with the axilla. The upside down triangle between these two points is the injection area, within approximately a 1 inch boundary of the deltoid muscle. This area can be visualized if the patient makes a fist and raises the elbow slightly to the side (Hahn, 1990) .
3. Pain perception is whatever the experiencing part icipant describes it as, occurring whenever the participant says it does. Pain onset can be slow or sudden, and mild to severe in nature (McCaffery, 1989) .
4. Injection speed is the rate at which fluid is injected, measured in seconds, from the time the plunger is pushed on the syringe until the medication is out of the syringe barrel. In this study injection speed was either 10 seconds per cubic centimeter (s/cc) or 30 s/cc. following outcome s. Krause (1997) , in a prospective, single blind, crossover study administered lidocaine to 29 volunteers in the dorsum of the hand. Each participant received four injections in random order, using a fast (1 s/cc) or slow (0.1 s/cc) injection speed of buffered or unbuffered lidocaine . Participants rated pain post-injection on a 100 mm visual analogue scale. It was found that reducing injection speed did not produce a statistically significant change in injection pain for either solution.
Scarfone (1998) conducted a single blind, prospective study administering four subcutaneous injections. The four injections were: • Buffered lidocaine at a speed of 5 s/cc. • Buffered lidocaine at a speed of 30 s/cc. • Unbuffered lidocaine at a speed of 5 s/cc. • Unbuffered lidocaine at a speed of 30 s/cc.
Each participant (N = 42) was administered a 1 cc injection into the forearm at four different sites to an injection depth of .25 inches. Both the sites and the injections were randomized. Pain was reported post-injection on a 100 mm long visual analogue scale. Each slow condition yielded significantly lower pain ratings than either rapid condition (p < .01). However, no difference was 288 found in pain perception for the slow buffered and slow unbuffered injections (p = .73). The authors concluded that administration rate of the injections had a greater impact on perceived pain than did buffering.
PURPOSE
The purpose of this research was to describe the effect of injection speed on pain perception. Because the 1M route is common to many worksite injections, it was chosen as the route of administration. The specific question to be answered was: Do participants who receive 1M injections of hepatitis B vaccine at a rate of 30 s/cc have more or less pain than those who receive the same injection at a rate of 10 s/cc?
METHODOLOGY

Design
Terms used in this study are defined in the Sidebar. The study design was a randomized crossover investigation of two injection rates . Sequential participants were assigned , in an alternating fashion , to receive first either the 10 s/cc or 30 s/cc injection . Injection speed and time were the independent variables, while pain perception was the dependent variable. All participants received two doses of hepatiti s B vaccine (1 cc)one injection at a speed of 10 s/cc and one at a speed of 30 s/cc. Participants were used as their own control. All injections were administered by the same registered nurse. A postcard method of pain perception reporting was used to provide privacy and to avoid having the participant feel any pressure to respond in one way or another about injection discomfort to please the investigator. Pain perception was measured over time at 0 hours, 12 hours, and 24 hours.
Participants were given a total of three 1M injections at the interval specified by the manufacturer, which is • The first dose at the elected date. • The second dose, 1 month later. • The third dose, 6 months after the first dose.
The third injection completed the required number of doses to achieve maximum seroconversion rates. Any two of the three injections were used to gather data on perception of pain, as this was most convenient to the researcher and allowed the maximum amount of data to be gathered.
Sample
The convenience sample (N = 50) was obtained from groups or individuals receiving hepatitis B vaccine at an occupational health service or in a community health clinic. All participants were adults, were able to understand English, and signed a consent to participate.
The sample included an unequal number of women (n = 41) and men (n = 9). Few variations in occupation were found. A large majority of the participants were school teachers or teachers aids (n = 41). The remaining 9 were either licensed practical nurses (n = 3), refinery hourly employees (n =3), a bus driver (n = 1), an insurance salesman for a health maintenance organization (n = 1), and a body piercer (n = 1).
Permission to conduct the study was obtained from the University of Wyoming Institutional Review Board prior to the start of the investigation. Each facility where participants were accessed also gave permission to conduct the research. The potential risk to participants was no greater than that of any individual receiving hepatitis B vaccine. While there was no indication prior to the research that the 10 s/cc injection would significantly effect discomfort. this injection rate had been specified in a previous study (Keen. 1986 ).
The 30 s/cc injection had no known potential to cause harm. The potential risks of hepatitis B vaccine were distributed in written form and explained to the participant prior to the injection. Participants were given an opportunity to ask questions and have them answered to their satisfaction about hepatitis B vaccine and the disease of hepatitis B. Signed consent was obtained prior to the first injection. Benefits to the participants included protection from hepatitis B and the satisfaction of participating in nursing research, which potentially could impact injection comfort in a positive way in the future.
Instruments
Participants were asked to complete a postcard containing a number in the return address section. but no name. to ensure confidentiality. The postcards were preaddressed to the researcher. The back of the postcard contained a 100 mm long horizontal line. Participants were asked to make an X mark on the horizontal line indicating their degree of injection discomfort. if any. These directions also were reiterated at the top of the postcard. with a blank line to indicate the time each participant was to fill out the card. The left side of the scale indicated no pain, and the right side of the scale indicated worst pain. The bottom of the card contained a blank line for the participant to note the time the postcard was actually completed.
Participants were asked to make three assessments of each injection speed. The first assessment, at 0 hours, was completed immediately post-injection. The next two assessments were at 12 hours. and again at 24 hours. Each participant was given two stamped postcards to take with them to complete at the appropriate time.
Each participant's number was recorded on a data spreadsheet as well as name. gender, weight (if stated). and height as stated. The X marks made by the participants on the horizontal analogue scale were measured with the same clear plastic ruler marked in millimeters , and entered into a spreadsheet in millimeters.
Methods and Procedures
Individuals who consented to participate were instructed to flex the elbow. with the lower arm supported so the deltoid was relaxed (Newton, 1992) . The skin was cleansed with isopropyl alcohol pads in a circular motion moving from the center outward (Keen, 1986) . The alcohol was allowed to dry (Newton, 1992) . Air was drawn up with the injectant in the amount of .25 cc to minimize leakage of solution into subcutaneous tissues (Friedrich, 1966) . A 3 cc syringe and a 25 gauge, I inch JUNE 2001, VOL. 49, NO.6 The finding that women had more injection pain than men was, thus, not limited to a particular injection speed of 10 s/cc or 30 s/cc, or a time point, but appeared instead to be affributable to gender. needle were used for each injection (Centers for Disease Control and Prevention, 1994) .
Needles were changed between drawing medication and patient injection (Keen. 1986 ). Needle puncture was made at a 90 0 angle to the skin into the deltoid muscle (Newton, 1992) . The needle was aspirated for 5 seconds , and if the syringe barrel was clear of blood , I cc of vaccine was injected (Keen, 1986) . Injection time was alternated between 10 s/cc and 30 s/cc. When the participant received the next dose of hepatitis B vaccine. the time of injection was reversed , so all participants had one injection at 10 s/cc and one at 30 s/cc. The investigator used a Timex" Ironman digital watch (Timex Corporation, Middlebury, CT) worn on the wrist during the injection to time the injection speed. The needle was withdrawn rapidly and the site was massaged briefly with a dry cotton ball (Keen. 1986 ). An adhesive strip bandage was used if necessary on the injection site.
METHODS OF ANALYSES
The mean, mode, median, and standard deviation were calculated for each data set. Frequency distributions were used to determine the shape of the distribution of the data. Three separate Wilcoxon matched-pairs signedrank tests compared the average pain perception of the participants for both the 10 s/cc and 30 s/cc injection at each time interval (0. 12, and 24 hours). The acceptable level of significance was p < .05.
Pain scores from both groups were pooled and assessed for a period effect. A period effect exists when a participant's capacity to respond to a treatment is affected by carryover effects of the treatment from an initial period to a subsequent period (Koch, 1984) .
Further analyses were undertaken to analyze the data for gender differences in pain perception. A two tailed Wilcoxon rank sum test for independent samples examined the difference in pain perception between women and men for the 10 s/cc and 30 s/cc injection at 0, 12. and 24 hours. An F test was used to analyze the samples of men and women for homogeneity of variance between the two groups.
RESULTS
The mean, median, mode, and standard deviation are listed in Table I . A large standard deviation was noted, indicating there were outliers in the data. An F test for variances indicated there was homogeneity of variance. 
Comparison of Pain Perception at Two Different Injection Speeds
Because individuals acted as the ir own controls, this was not surprising to the researchers.
Frequency distributions for both of the injection speeds at each time measurement were calculated and showed a significant negati ve skew. Immediate visual analogue scale (VAS) pain scores, those at the 0 hour measurement, showed that 50% reported pain below lOon a 0 to 100 mm VAS. Thi s skew becomes even more pronounced at 12 and 24 hours when approximately 80% of the participants report pain scores of less than 10.
To determine if parti cipants had more or less pain at differing injection rate s, the Wilcoxon matched-pairs signed-rank test was conducted on the data sets (see Table  2 ). It was found that for the 10 s/cc and 30 slcc injection speed at 0, 12, or 24 hours there was no statistically significant difference in pain perception. However, a trend away from the implied hypothesis (i.e., a slower injection could cause more pain) was noted. The z score for the comparison of pain between the 0 hour 10 s/cc and 30 s/cc injection was -1.08 (critical z =± 1.96 for p < .05). The Pain scores from both groups were pooled and assessed for a period effect. With the first injection, 21 participants had more pain. With the second injection 28 participants had more pain (p > .05 by Wilcoxon rank sum analy sis). Therefore, it was noted there was no period effect.
Analysis was conducted to detect gender differences in pain perception (women, n =41; men , n =9). Women consistently had higher mean pain scores than men for both injection speeds at every time interval (see Table 3 ). The difference in mean pain perception scores for the two groups was remarkable-about 2.5 times higher in women for all time points, except for the 0 hour 30 slcc injection, where the difference was 1.4 times greater than men. An F test showed that despite the differences in mean pain scores, there was homogeneity of variance. The mode and median again showed low scores of pain perception overall. Because of the remarkable difference in the means between the two groups, the data were analyzed for gender differences in pain perception using a two tailed Wilcoxon rank sum test for independent samples (see Table 3 ).
Th is analysis revealed a significant gender difference in pain perception. Women had significantly more pain than the men did at the 0 hour 10 s/cc injection (z = -2.3, critical 2 = ± 1.96 for p < .05). Thus, women who received 1M injections of hepatitis B at a rate of 10 s/cc had more pain immediately post-injection than men who received the same injection at 10 s/cc.
A trend toward significance also was noted at the other time points with both inj ection speeds, particularly the 12 hour 30 s/cc inj ection (z = -1.0, critical z = ± 1.96), and the 24 hour 30 s/cc injection (2 = -1.93, critical 2 =± 1.96). The finding that women had more inje ction pain than men was, thus, not limited to a particular injection speed of 10 s/cc or 30 s/cc, or a time point, but appeared instead to be attributable to gender. 
DISCUSSION
Occupational health nurses frequently administer injections as a part of worksite health promotion programs. Injections are a rather routine procedure. However, correct and careful administration may affect the comfort and number of participants in such programs. Nursing research literature and articles on injection technique frequently instruct nurses to "inject slowly." The reasons to inject slowly cited in the literature review were to aid absorption, avoid creating high pressure in the muscle, and to prevent sudden tissue distention. Some researchers have quantified "slowly" as 5 s/cc to 10 s/cc, but no research studying speed of injection as a single variable in 1M injection pain was found.
The purpose of this research was to study the effect of 1M injection speed on pain perception. It was designed to answer the question: Do participants who receive an 1M injection of hepatitis B vaccine at a rate of 30 s/cc have more or less pain than those who receive the same injection at a speed of 10 s/cc?
This study showed that slowing injection speed beyond 10 s/cc did not decrease pain perception significantly. The data at some point, perhaps before 10 slcc, but certainly after, have the shape of an asymptotic function, with the asymptote being approached at or before 10 s/cc. The data suggest that after 10 s/cc of injection time, no additional benefit is derived by injecting at a slower rate. Therefore, the discomfort caused by speed of injection may occur at a rate faster than 10 s/cc.
While the study by Scarfone (1998) differed in injection route and administered solution from the current study, it showed that a 30 s/cc injection caused less pain than a 5 s/cc injection. If one combined the results of the current study and those of Scarfone, one might assume that perceived pain related to injection speed occurs at a rate of less than 10 s/cc, and is present at 5 s/cc. Rather than relying on this extrapolation, additional research JUNE 2001, VOL. 49, NO.6 could compare pain perception between a 10 s/cc injection and a 5 s/cc injection.
Gender differences in perception of injection pain were discovered. It was found there was a significant difference in pain perception at the 0 hour 10 s/cc injection measurement between men and women. Women experienced significantly more pain than men at this measurement. The trend also was suggested at other measurements regardless of the injection speed or the time of measurement. Perhaps the smaller muscle mass of the women distended more, increasing pain perception. This assumes the women's deltoid muscle masses were smaller than men's in this study. Other authors have suggested a similar rationale for the finding of a gender difference in pain perception. Kruszewski (1979) suggested anatomical differences in muscular structure between men and women influenced pain perception. The authors found that women experienced significantly less discomfort when they received an injection of diazepam, a chemically irritating solution, when positioned with femurs internally rotated for an 1M injection versus externally rotated. Men had no difference in pain perception, whether in internal femoral rotation or external. The authors suggested the difference had more to do with anatomical gender differences in the muscle than with position. Vallerand (1995) noted in a review of the literature from 1966 to 1994 that with respect to experimentally induced pain, in most studies, women were reported to have a lower pain threshold and tolerance than men, and this difference appeared to be a result of gender alone. The author concluded that questions arise of whether anatomic or hormonal differences contribute to pain perception or whether women are more likely to report pain. The present study, in which women reported mean pain perception scores consistently greater than men, supports either or both theories of an anatomical difference in muscle structure or an increased likelihood to report pain in women.
STUDY LIMITATIONS
This study was limited by the number of participants. A sample number of 50 participants was chosen, consistent with the average number of participants in other injection studies cited in the review of the literature. However, a power calculation at a 95% confidence level indicated that 300 participants would have been preferable to reach the level of significance with more reliability. The study also was limited because it was a convenience sample, and not balanced in relation to participant gender. Convenience samples can lead to sample bias and reduce generalizability.
Can the low scores on a VAS be interpreted as significant pain? The study did not attempt to answer that question. It was designed instead to measure whether the difference in pain perception of one injection time versus another was significant. The reported pain scores in this study were similar to those of others (Krause 1997; Scarfone, 1998) . While the recommended length of a VAS is 100 mm (Miller, 1993) , it appears that when this relatively long line is used to measure the perception of pain in a minimally painful procedure, the scores tend to be low, skewing the distribution negatively and potentially affecting the analysis. Perhaps there is a better tool for measuring minimally painful procedures than the VAS. Casson (1997) found that the FACES pain scale and the Present Pain Intensity (PPI) scale yielded significant differences in adults when assessing the use of a distraction technique during phlebotomy, while the VAS results only approached significance, with a smaller effect size in that study.
Therefore, another limitation of this study might be the use of a VAS. Future researchers may attempt to use the VAS or FACES and PPI scales to validate the effectiveness of the VAS as a self report tool in minimally painful procedures.
CONCLUSION
It is most important to remember this study did not support or negate the theory that injections should be administered slowly. It only showed that for hepatitis B solution, a 30 s/cc rate of injection did not cause less pain than the 10 s/cc injection. The clinical implication is that until further research has been conducted, occupational health nurses should be following injection theory and administering injections no faster than 5 s/cc to 10 s/cc.
As with all research, there are incidental findings. This study discovered an interesting point about gender differences and injection pain. Women experienced significantly more pain than men with the 0 hour 10 s/cc injection. This may be a function of anatomical gender differences, specifically muscle size, or that women are more likely to report pain. While more research is needed in the area of pain perception and gender differences, occupational health nurses should be aware of this difference in the workplace when administering injections.
